CD276 and prostate carcinoma: In contrast, in a study using the TRAMP PC mouse model (RB1 and TP53 loss of function), B7-H3 knockout generated an immunosuppressive tumour microenvironment (TME) and promoted tumour growth, although this model’s predominantly neuroendocrine phenotype differs from most human prostate carcinomas (17).